Bank of New Hampshire Purchases 8,281 Shares of SPDR S&P Biotech ETF $XBI

Bank of New Hampshire lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 95.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,961 shares of the exchange traded fund’s stock after buying an additional 8,281 shares during the period. Bank of New Hampshire’s holdings in SPDR S&P Biotech ETF were worth $2,674,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in XBI. Bank of America Corp DE lifted its position in shares of SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after acquiring an additional 1,700,851 shares during the period. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $256,053,000. OMERS ADMINISTRATION Corp boosted its position in SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after acquiring an additional 1,187,907 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of SPDR S&P Biotech ETF by 61.4% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 691,000 shares of the exchange traded fund’s stock worth $84,254,000 after purchasing an additional 263,000 shares during the period. Finally, Hsbc Holdings PLC lifted its position in SPDR S&P Biotech ETF by 7.8% during the fourth quarter. Hsbc Holdings PLC now owns 638,529 shares of the exchange traded fund’s stock worth $78,049,000 after buying an additional 46,339 shares during the period.

SPDR S&P Biotech ETF Stock Down 3.4%

Shares of XBI traded down $5.29 during mid-day trading on Tuesday, hitting $150.90. The company had a trading volume of 17,219,941 shares, compared to its average volume of 9,131,324. SPDR S&P Biotech ETF has a 1-year low of $102.55 and a 1-year high of $169.89. The business’s 50-day simple moving average is $158.43 and its 200-day simple moving average is $145.30. The stock has a market cap of $9.91 billion, a PE ratio of 11.47 and a beta of 0.83.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.